rs79654911
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM5PP3_Moderate
The ENST00000399286.3(KCNE1):c.200G>A(p.Arg67His) variant causes a missense change. The variant allele was found at a frequency of 0.0000903 in 1,538,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R67C) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000399286.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNE1 | NM_000219.6 | c.200G>A | p.Arg67His | missense_variant | 4/4 | ENST00000399286.3 | NP_000210.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNE1 | ENST00000399286.3 | c.200G>A | p.Arg67His | missense_variant | 4/4 | 1 | NM_000219.6 | ENSP00000382226 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000179 AC: 24AN: 134000Hom.: 0 Cov.: 17
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251394Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135902
GnomAD4 exome AF: 0.0000819 AC: 115AN: 1404590Hom.: 0 Cov.: 26 AF XY: 0.0000870 AC XY: 61AN XY: 701296
GnomAD4 genome AF: 0.000179 AC: 24AN: 134000Hom.: 0 Cov.: 17 AF XY: 0.000201 AC XY: 13AN XY: 64662
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 17, 2024 | Published functional studies suggest that p.(R67H) may impact channel function; nevertheless, it is unclear how these studies may translate to a pathogenic role in vivo (PMID: 21576493); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in at least one patient with LVNC in published literature (PMID: 30371277, 31397097); Identified in patients with sudden unexplained death (SUD) and unexplained intrauterine fetal death (IUFD) (PMID: 29672598, 21070882, 32145446, 33762593); This variant is associated with the following publications: (PMID: 26410412, 22581653, 25637381, 24710009, 19716085, 34426522, 31679457, 32058015, 31397097, 30847666, 23631430, 31941373, 33281875, 21070882, 33762593, 30461122, 32145446, 30371277, 29672598, 21576493) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 03, 2021 | - - |
Long QT syndrome Uncertain:2
Uncertain significance, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 28, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 67 of the KCNE1 protein (p.Arg67His). This variant is present in population databases (rs79654911, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of KCNE1-related conditions (PMID: 19716085, 21070882, 24710009, 31941373). ClinVar contains an entry for this variant (Variation ID: 132661). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNE1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects KCNE1 function (PMID: 21576493). This variant disrupts the p.Arg67 amino acid residue in KCNE1. Other variant(s) that disrupt this residue have been observed in individuals with KCNE1-related conditions (PMID: 31941373), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Nov 06, 2014 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. KCNE1 p.Arg67His The variant was re-reviewed on November 6, 2014. There was no new data. Based on the data reviewed below we consider this a variant of uncertain significance, likely disease-causing. We hesitate to classify this variant as likely disease-causing given the case data is mostly unpublished cases (some without clinical data) and that it is present in controls, albeit in a small number of individuals. The variant was reviewed at an SCICD team meeting and the team agreed upon this classification. The variant has been seen in at least 8 unrelated cases, (most without good clinical data to determine LQTS) and one case of sudden cardiac arrest, with possible failure to segregate in one case. The p.Arg67His variant is a conservative amino acid substitution of one positively charged residue for another. This variant is located in exon 3 of the KCNE1 gene in the C-terminal region. This variant has been reported in one individual referred for LQTS testing (Kapplinger et al., 2009). This was a report of 2500 individuals tested for LQTS through Familion laboratories. No individual data was given for this individual. Another variant at the same codon Arg67Cys was also reported in one individual in this cohort. Of the 902 individuals who had a rare variant in one of the tested genes, 24 of the them had a variant in KCNE1 gene. Of note in considering the cases reported by Kapplinger et al (2009) is the lack of phenotypic data on this cohort, the low yield of 36% (vs. 70% in cohorts with firm diagnoses of long QT), and the lack of clarity regarding which variants were seen with another variant (9% of the cohort had multiple variants). Per an email from Familion, they have seen it in 5 probands referred for LQTS testing (presumably including the case reported by Kapplinger in 2009). All probands were caucasian and four of the QT measurements were 488-556ms, 520m, 481ms and 474ms. They report a positive family history was seen in at least two probands, but they do not have segregation data. GeneDx reports that Arg67His and several other novel changes, Arg67Leu, Arg67Ser and Arg67Gly have been observed in several unrelated individuals referred for LQTS testing at GeneDx. GeneDx clarified that they have seen the R67H variant in at least three individuals tested for LQTS, with no segregation data. This variant was also reported in a case of sudden unexplained death in a 17 year old female. Testing was done post-mortem. She was found dead in bed. A few months earlier she had experienced a nocturnal seizure with enuresis. Her other medical history was unremarkable. Her mother, whose nephew had died of cot death in infancy, had maximal QTc of 470 msec. However, the mother had no symptoms and did not carry the R67H variant. The father declined testing. The authors indicate that this variant was also seen in a girl with LQTS in Norway and that her mother had a normal QT interval and was also a gene carrier. No reference was given and I could not find another case report of this variant (Skinner et al., 2011 on behalf of the Cardiac Inherited Disease Group New Zealand). There are two ClinVar entries, both from Cardiovascular Biomedical Research Unit Royal Brompton & Harefield NHS Foundation Trust. One notes an assertion of pathogenic (SCV000153792). Neither provide any internal data. In silico analysis with PolyPhen-2 predicts the variant to be possibly damaging. Mutation Taster predicts this variant to be disease-causing. The arginine at codon 67 is conserved across species, as are neighboring amino acids. Other variants have been reported in association with disease at this codon (Arg67Cys; Arg67Ser; Arg67Gly) and nearby co - |
Long QT syndrome 5;C2676723:Jervell and Lange-Nielsen syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 12, 2022 | - - |
Jervell and Lange-Nielsen syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 13, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 18, 2022 | The c.200G>A (p.R67H) alteration is located in exon 3 (coding exon 1) of the KCNE1 gene. This alteration results from a G to A substitution at nucleotide position 200, causing the arginine (R) at amino acid position 67 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Long QT syndrome 5 Other:1
not provided, no classification provided | in vitro | Roden Lab, Vanderbilt University Medical Center | - | - - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at